PubMed (GeneRIF) for id: 9622

Year	Number of Results
2002	1
2004	2
2005	2
2006	3
2007	2
2008	5
2009	5
2010	9
2011	1
2012	3
2013	3
2014	4
2015	7
2016	5
2017	6
2018	4
2019	7
2020	3
2021	1
2022	2
2023	2
2024	1

1

Shi J, Qi Y, Sun Y, Huang Y. Shi J, et al. Am J Pathol. 2024 Jan;194(1):121-134. doi: 10.1016/j.ajpath.2023.10.006. Epub 2023 Oct 31. Am J Pathol. 2024. PMID: 37918799

2

KLK4 Silencing Inhibits the Growth of Chromophobe Renal Cell Carcinoma through ERK/AKT Signaling Pathway.

Fan B, Niu Y, Zhang A, Wei S, Ma Y, Su J, Ren Z. Fan B, et al. Kidney Blood Press Res. 2022;47(12):702-710. doi: 10.1159/000527412. Epub 2022 Oct 19. Kidney Blood Press Res. 2022. PMID: 36260980 Free article.

3

Loss of KLK4::KLKP1 pseudogene expression by RNA chromogenic in-situ hybridization is associated with PTEN loss and increased risk of biochemical recurrence in a cohort of middle eastern men with prostate cancer.

Bakker A, Slack JC, Palanisamy N, Carskadon S, Ghosh S, Khalifeh I, Bismar TA. Bakker A, et al. J Cancer Res Clin Oncol. 2023 Jul;149(7):3721-3728. doi: 10.1007/s00432-022-04279-5. Epub 2022 Aug 18. J Cancer Res Clin Oncol. 2023. PMID: 35982181

4

lncRNA IGF2-AS promotes the osteogenic differentiation of bone marrow mesenchymal stem cells by sponging miR-3,126-5p to upregulate KLK4.

Tang JZ, Zhao GY, Zhao JZ, Di DH, Wang B. Tang JZ, et al. J Gene Med. 2021 Oct;23(10):e3372. doi: 10.1002/jgm.3372. Epub 2021 Jul 16. J Gene Med. 2021. PMID: 34101307

5

MicroRNA-378-3p/5p represses proliferation and induces apoptosis of oral squamous carcinoma cells via targeting KLK4.

Cui Z, Bao X, Liu Q, Li Q, Huang L, Wang H, Jiao K. Cui Z, et al. Clin Exp Pharmacol Physiol. 2020 Apr;47(4):713-724. doi: 10.1111/1440-1681.13235. Epub 2020 Jan 20. Clin Exp Pharmacol Physiol. 2020. PMID: 31868942

6

MiR-378a-5p inhibits angiogenesis of oral squamous cell carcinoma by targeting KLK4.

Cui Z, Liu QL, Sun SQ, Jiao K, Liu DR, Zhou XC, Huang L. Cui Z, et al. Neoplasma. 2020 Jan;67(1):85-92. doi: 10.4149/neo_2019_190306N191. Epub 2019 Dec 9. Neoplasma. 2020. PMID: 31829025

7

Crystal structure of the inhibitor-free form of the serine protease kallikrein-4.

Riley BT, Hoke DE, McGowan S, Buckle AM. Riley BT, et al. Acta Crystallogr F Struct Biol Commun. 2019 Aug 1;75(Pt 8):543-546. doi: 10.1107/S2053230X19009610. Epub 2019 Jul 16. Acta Crystallogr F Struct Biol Commun. 2019. PMID: 31397325 Free PMC article.

8

MicroRNA-378-3p/5p suppresses the migration and invasiveness of oral squamous carcinoma cells by inhibiting KLK4 expression.

Cui Z, Sun S, Liu Q, Zhou X, Gao S, Peng P, Li Q. Cui Z, et al. Biochem Cell Biol. 2020 Apr;98(2):154-163. doi: 10.1139/bcb-2019-0017. Epub 2019 Jul 2. Biochem Cell Biol. 2020. PMID: 31265790

9

Mucin 16 and kallikrein 13 as potential prognostic factors in colon cancer: Results of an oncological 92-multiplex immunoassay.

Björkman K, Mustonen H, Kaprio T, Haglund C, Böckelman C. Björkman K, et al. Tumour Biol. 2019 Jul;41(7):1010428319860728. doi: 10.1177/1010428319860728. Tumour Biol. 2019. PMID: 31264534 Free article.

10

Circular RNA (hsa_circ_0051240) promotes cell proliferation, migration and invasion in ovarian cancer through miR-637/KLK4 axis.

Zhang M, Xia B, Xu Y, Zhang Y, Xu J, Lou G. Zhang M, et al. Artif Cells Nanomed Biotechnol. 2019 Dec;47(1):1224-1233. doi: 10.1080/21691401.2019.1593999. Artif Cells Nanomed Biotechnol. 2019. PMID: 30945557

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

67 results

Results by year